Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a short, Family-Focused program replace hospital stays for suicidal teens?

NCT ID NCT06476886

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing a brief, intensive program for adolescents who come to the hospital with suicidal thoughts or behavior. The program, called Intensive Crisis Intervention, packs individual and family sessions into a few days and teaches skills to change how teens respond to stress. The trial compares this approach with traditional inpatient psychiatric care, measuring satisfaction, family functioning, and changes in suicidal thoughts over three months. About 213 teens and their families are expected to take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Intensive Crisis Intervention (ICI), a brief family-centered, skills-based program
What this could lead to
If it works, this could give families a shorter, home-based option for stabilizing a teen in crisis instead of a longer hospital stay.
What could go wrong
The trial may show the program is no better than standard inpatient care, or that it only helps certain families. Teens in crisis need close monitoring, and a brief program may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 213 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Youth between the ages of 12 years 0 months and 17 years 6 months at time of consent 2. Present to the Nationwide Children's Hospital (NCH) Psychiatric Crisis Department (PCD) or NCH Psychiatry Consult Liaison (CL) Service with suicidal ideation and/or behavior as the primary referral 3. Be eligible for admission to both YCSU and APIU based on PCD or CL clinician's clinical judgement 4. Patient and legal guardian must be willing to be admitted to either YCSU or APIU 5. Youth obtains a score of ≥23 on the Concise Health Risk Tracking Self-Report (CHRT-SR) 6. Youth resides with a primary caretaker who has legal authority to consent for participation in research 7. Legal guardian must attend the PCD or CL evaluation Exclusion Criteria: 1. Participants who are unable to understand study procedures (e.g., intellectual disability, actively psychotic) 2. Inability to speak or read English adequately to understand and complete study consent and procedures YCSU clinicians, PCD staff, and NCH-BH leaders will be invited to participate based on their roles in the system-of-care.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicidal ideation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Self-Injurious Behavior Suicidal Ideation Suicide Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nationwide Children's Hospital

    RECRUITING

    Columbus, Ohio, 43215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.